{"result": "(\"entity\"<|>DENSIDAD ENERGÉTICA<|>EVENT<|>Densidad energética refers to the amount of energy contained in food per unit weight, which is a key concept in understanding dietary energy intake.)\n##\n(\"entity\"<|>ALIMENTOS<|>ORGANIZATION<|>Alimentos refers to food items that are being analyzed for their energy density and nutritional content.)\n##\n(\"entity\"<|>PACIENTES ADULTOS<|>PERSON<|>Pacientes adultos refers to adult patients who may be prescribed VLCD for weight loss due to obesity and related health issues.)\n##\n(\"entity\"<|>MECANISMOS DE DISTENSIÓN GÁSTRICA<|>EVENT<|>Mecanismos de distensión gástrica are physiological processes that contribute to the feeling of fullness and satiety after eating.)\n##\n(\"entity\"<|>RACIONES<|>EVENT<|>Raciones refer to portion sizes of food that have increased over the years, impacting dietary habits and energy intake.)\n##\n(\"entity\"<|>MOTIVOS DE SALUD<|>EVENT<|>Motivos de salud refer to health-related reasons that may necessitate weight loss, such as obesity-related complications.)\n##\n(\"entity\"<|>DURACIÓN DE USO<|>EVENT<|>Duración de uso refers to the length of time that VLCDs are recommended for patients, which is typically not exceeding 16 weeks.)\n##\n(\"relationship\"<|>ALIMENTOS<|>DENSIDAD ENERGÉTICA<|>Alimentos are analyzed for their densidad energética to understand their caloric content and nutritional value<|>8)\n##\n(\"relationship\"<|>PACIENTES ADULTOS<|>VLCD<|>Pacientes adultos may be prescribed VLCD to manage obesity and related health conditions<|>8)\n##\n(\"relationship\"<|>MECANISMOS DE DISTENSIÓN GÁSTRICA<|>DENSIDAD ENERGÉTICA<|>Mecanismos de distensión gástrica are influenced by the density energética of the food consumed, affecting satiety<|>7)\n##\n(\"relationship\"<|>RACIONES<|>DENSIDAD ENERGÉTICA<|>Raciones have increased in size, which can affect the density energética of the diet and overall caloric intake<|>7)\n##\n(\"relationship\"<|>MOTIVOS DE SALUD<|>VLCD<|>Motivos de salud are often the reason for prescribing VLCD to patients with obesity<|>8)\n##\n(\"relationship\"<|>DURACIÓN DE USO<|>VLCD<|>Duración de uso indicates the recommended time frame for which VLCD should be followed<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , de\nla densidad energética de los alimentos. La densidad       15 de septiembre, y hace referencia a aspectos relati-\nenergética (DE) de los alimentos se define como la can-    vos a su composición, etiquetado y duración de uso.\ntidad de energía contenida en un alimento por unidad         Las VLCD están indicadas en pacientes adultos obe-\nde peso del alimento (kcal/g). Está condicionada fun-      sos que hayan fracasado en intentos previos de pérdi-\ndamentalmente por el contenido en agua y grasa de          da de peso con dietas moderadamente hipocalóricas\nlos alimentos por aportar estos el mínimo (0 kcal/g) y el  (tabla 3). También podrían prescribirse cuando sea\nmáximo (9 kcal/g) contenido calórico, respectivamen-       necesaria una pérdida de peso rápida por motivos de\nte. La mayoría de los estudios han encontrado una re-      salud, o en pacientes con sobrepeso grado II (IMC >\n                                                           27 kg/m2 ) u obesidad moderada que presenten comor-\nlación directa entre la densidad energética de la dieta y\nel consumo de calorías y ganancia de peso.                 bilidades asociadas (apnea del sueño, diabetes tipo 2,\n   La relación entre DE y peso corporal es compleja. Por   dislipemia, artrosis). Su empleo no se recomienda du-\nun lado, tendemos a consumir un volumen constante          rante períodos superiores a 16 semanas. Entre sus con-\nde comida que genera saciedad por mecanismos me-           traindicaciones se encuentran:\ncánicos de distensión gástrica; la ingesta de un volu-\nmen similar de alimentos con mayor DE producirá un           •   Embarazo y lactancia.\naumento en la ingesta calórica. Por otro lado, los ali-      •   Enfermedades con compromiso del estado nutri-\nmentos con elevada DE se relacionan con una mayor                cional.\npalatabilidad (por mayor contenido de grasa) y esta a        •   Enfermedades cardíacas como angina inestable,\nmás ingesta de comida. Además, con frecuencia los                infarto de miocardio reciente, arritmias malignas,\nalimentos energéticamente más densos son más bara-               QT prolongado o antecedentes de síncope cardio-\ntos. Los estudios de intervención en los que a los pa-           génico.\ncientes se les instruye para disminuir la DE muestran        •   Enfermedad cerebrovascular reciente o recurrente.\nuna reducción de peso significativa, mayor cuanto más        •   Insuficiencia renal.\nse reduce la DE de la dieta.                                 •   Cirrosis hepática o hepatopatías graves.\n   Distintos estudios han resaltado el aumento del ta-       •   Enfermedades psiquiátricas como los trastornos de\nmaño de las raciones en los últimos años, resaltando el          la conducta alimentaria, la dependencia de alcohol\n---\n                                                                                  Tema 7.    Tratamiento dietético de la obesidad      123\n\n\n\nTabla 3.    Indicaciones y contraindicaciones de las dietas de muy bajo contenido calórico.\n\n\n\n                             Indicaciones                                                         Contraindicaciones\n  ·  Pacientes entre 18 y 65 años                                           ·  Infarto de miocardio reciente\n  ·  Obesidad: Índice de masa corporal (IMC) superior a                     ·  Trastorno de conducción cardiaca\n     30 kg/m2                                                               ·  Antecedentes de enfermedad cerebrovascular, renal, o\n      –  Fracaso en intentos previos de pérdida de peso                        hepática\n         con dietas moderadamente hipocalóricas y alta                      ·  Diabetes mellitus tipo 1\n         motivación                                                         ·  Trastornos psiquiátricos mayores\n      –  Riesgos para la salud derivados de la obesidad que                 ·  Colelitiasis\n         hacen imperativa la pérdida de peso                                ·  Alcoholismo\n      –  Pacientes en que se precise una pérdida de peso                    ·  Cáncer\n         rápida por cirugía                                                 ·  Infección\n  ·  Sobrepeso grado II (IMC > 27) con comorbilidades                       ·  Abuso de sustancias\n     mayores (apnea del sueño, diabetes mellitus tipo 2,                    ·  Anorexia/Bulimia\n     dislipemia, artrosis)\n\n\n\n       o drogas, trastornos depresivos mayores o intentos                       La mayoría de los efectos adversos observados con el\n       de suicidio.                                                          uso de VLCD son de carácter leve y transitorio. Estos\n                                                                             comprenden molestias gastrointestinales (náuseas o\n   Deben emplearse con especial precaución en adoles-                        estreñimiento), o síntomas generales como astenia,\ncentes por el riesgo de comprometer su crecimiento;                          frío, sensación de mareo, hambre o aliento cetósico). El\nen ancianos, dada\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>VLCD<|>ORGANIZATION<|>VLCD refers to Very Low-Calorie Diets, which are indicated for adults with obesity who have failed previous weight loss attempts and may require rapid weight loss for health reasons.)\n##\n(\"entity\"<|>DIABETES TIPO 2<|>EVENT<|>Diabetes tipo 2 is a health condition that can be a comorbidity associated with obesity and may necessitate weight loss.)\n##\n(\"entity\"<|>OBESIDAD<|>EVENT<|>Obesidad refers to a condition characterized by excessive body fat, which can lead to various health complications and is a primary focus for VLCD.)\n##\n(\"entity\"<|>APNEA DEL SUEÑO<|>EVENT<|>Apnea del sueño is a sleep disorder that can be a comorbidity associated with obesity, indicating the need for weight loss.)\n##\n(\"entity\"<|>ARTROSIS<|>EVENT<|>Artrosis is a degenerative joint disease that can be exacerbated by obesity, making weight loss imperative for health.)\n##\n(\"entity\"<|>CÁNCER<|>EVENT<|>Cáncer is a serious health condition that can be influenced by obesity, highlighting the importance of weight management.)\n##\n(\"entity\"<|>ENFERMEDADES CARDÍACAS<|>EVENT<|>Enfermedades cardíacas encompass various heart conditions that can be aggravated by obesity, necessitating weight loss interventions.)\n##\n(\"entity\"<|>ENFERMEDADES PSIQUIÁTRICAS<|>EVENT<|>Enfermedades psiquiátricas refer to mental health disorders that can complicate weight loss efforts and are considered contraindications for VLCD.)\n##\n(\"entity\"<|>MOTIVACIÓN<|>PERSON<|>Motivación refers to the psychological drive that can influence an individual's success in weight loss efforts, particularly in the context of VLCD.)\n##\n(\"entity\"<|>PACIENTES<|>PERSON<|>Pacientes refers to individuals who may be prescribed VLCD for weight loss due to obesity and related health issues.)\n##\n(\"relationship\"<|>PACIENTES<|>VLCD<|>Pacientes are individuals who may be prescribed VLCD to manage obesity and related health conditions<|>8)\n##\n(\"relationship\"<|>OBESIDAD<|>VLCD<|>VLCD is indicated for individuals suffering from obesity to facilitate weight loss<|>9)\n##\n(\"relationship\"<|>DIABETES TIPO 2<|>OBESIDAD<|>Diabetes tipo 2 is a health condition that can be a comorbidity of obesity<|>7)\n##\n(\"relationship\"<|>APNEA DEL SUEÑO<|>OBESIDAD<|>Apnea del sueño is a condition that can be associated with obesity<|>7)\n##\n(\"relationship\"<|>ARTROSIS<|>OBESIDAD<|>Artrosis can be exacerbated by obesity, making weight loss important<|>7)\n##\n(\"relationship\"<|>CÁNCER<|>OBESIDAD<|>Cáncer can be influenced by obesity, highlighting the need for weight management<|>7)\n##\n(\"relationship\"<|>ENFERMEDADES CARDÍACAS<|>OBESIDAD<|>Enfermedades cardíacas can be aggravated by obesity, necessitating weight loss<|>7)\n##\n(\"relationship\"<|>ENFERMEDADES PSIQUIÁTRICAS<|>OBESIDAD<|>Enfermedades psiquiátricas can complicate weight loss efforts in obese individuals<|>6)\n<|COMPLETE|>"}]}